Tuberculosis risk among medical trainees, Pune, India

Citation: Basavaraj A, Chandanwale A, Patil A, Kadam D, Joshi S, Gupte N, McIntire K, Jain D, Dalal H, Badave R, DeLuca A, Gupta A, Bollinger R, Mave V. Tuberculosis risk among medical trainees, Pune, India. Emerg Infect Dis. 2016 Mar;22(3):541-3. doi: 10.3201/eid2203.151673.

Access full article:

http://www.ncbi.nlm.nih.gov/pubmed/26889712

During 2012-2013, at a public hospital in Pune, India, 26 (3.9%) cases of tuberculosis were reported among 662 medical trainees, representing an estimated incidence of 3,279 cases/100,000 person-years. Three of these infections were isoniazid-resistant, 1 was multidrug-resistant, and 1 occurred in a trainee who had fulminant hepatitis after starting treatment for TB.

Emerg Infect Dis. 2016 Mar;22(3):541-3. doi: 10.3201/eid2203.151673. PMID: 26889712 

Categories

CRS
Topics

Clinical Trials

NWCS 408: Examining Longitudinal Cytokine Profiles in HIV-TB...

Using existing data from A5274 and data obtained from retrospectively testing available biospecimens, we propose the following...

Read More

P2026: Pharmacokinetic Properties of Antiretroviral and...

IMPAACT P1026s, the predecessor of this study, was first approved in 2003. P1026s enrolled over 1000 pregnant/postpartum women,...

Read More

P2005: A Phase I/II Open-Label, Single-Arm Study to Evaluate...

This study is currently on hold. The study is designed to characterize the pharmacokinetics of DLM using a model-based...

Read More

HPTN 078: Enhancing Recruitment, Linkage to Care and...

The purpose of this study is to develop and assess the efficacy of an integrated strategy that includes feasible and scalable...

Read More

P1070, Dose-Finding and Pharmacogenetic Study of Efavirenz...

Efavirenz (EFV) is an anti-HIV medicine that is commonly used to treat HIV infection in adults and children older than 3 years...

Read More